Viewing Study NCT06049095


Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-02-20 @ 6:33 PM
Study NCT ID: NCT06049095
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2023-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants
Sponsor: Latigo Biotherapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module